18523-22-3

Basic information

• Product Name: 3-BROMOPHENACYL BROMIDE
• Synonyms: M-BROMOPHENACYL BROMIDE;BUTTPARK 41\03-59;A,3'-DIBROMOACETOPHENONE;A,3-DIBROMOACETOPHENONE;AKOS BBS-00000935;ALPHA,3'-DIBROMOACETOPHENONE;3-BROMOPHENACYL BROMIDE;3'-BROMOPHENACYLBROMIDE
• CAS NO: 18523-22-3
• Molecular Formula: C₈H₆Br₂O
• Molecular Weight: 277.94
• Mol File: 18523-22-3.mol
• Article Data: 66

Chemical Properties

• Melting Point: 47-52 °C(lit.)
• Boiling Point: 305.856 °C at 760 mmHg
• Flash Point: >110℃
• Appearance: light yellow crystalline powder
• Density: 1.849 g/cm³
• Vapor Pressure: 0.0008mmHg at 25°C
• Refractive Index: 1.603
• Storage Temp.: Keep Cold
• Solubility: DMSO (Slightly)
• Water Solubility: Insoluble in water.
• Sensitive: Lachrymatory
• Stability: Moisture Sensitive
• BRN: 775786
• CAS DataBase Reference: 3-BROMOPHENACYL BROMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BROMOPHENACYL BROMIDE(18523-22-3)
• EPA Substance Registry System: 3-BROMOPHENACYL BROMIDE(18523-22-3)

Safety Data

• Hazard Codes: C
• Statements: 34
• Safety Statements: 26-36/37/39
• RIDADR: UN 3261 8/PG 2
• WGK Germany: 3
• HazardClass: 8
• PackingGroup: III
• Hazardous Substances Data: 18523-22-3(Hazardous Substances Data)

Usage

Chemical Properties

light yellow crystalline powder

Uses

Different sources of media describe the Uses of 18523-22-3 differently. You can refer to the following data:
1. It is employed as an intermediate for pharmaceutical and organic synthesis.
2. 3-Bromophenacyl bromide is a useful intermediate for pharmaceutical and organic synthesis.

InChI:InChI=1/C8H6Br2O/c9-5-8(11)6-2-1-3-7(10)4-6/h1-4H,5H2

Upstream product

• 2142-63-4 1-(3-Bromophenyl)ethanone 
• 52780-14-0 1-(3-bromophenyl)ethanol 
• 766-81-4 3-bromophenylacetylene 
• 2039-86-3 3-bromostyrene 
• 67-56-1 methanol 
• 598-55-0 methyl carbamate 

Downstream Products

• 5331-39-5 4-(3-bromo-phenacylmercapto)-2,6-dimethyl-pyrylium; bromide 
• 802553-61-3 1-(3-bromo-phenyl)-2-(2-imino-thiazolidin-3-yl)-ethanone 
• 10505-54-1 1-(3-bromo-phenyl)-2-(2-imino-thiazol-3-yl)-ethanone 
• 6096-70-4 {[2-(3-Bromo-phenyl)-2-oxo-ethyl]-methoxycarbonylmethyl-amino}-acetic acid methyl ester 
• 27047-20-7 (3-Methylphenyl)-(3'-brom-phenacyl)-sulfid 
• 134044-47-6 2-(3-Bromo-phenyl)-imidazo[1,2-a]pyrimidine 
• 221179-06-2 2-amino-6-[2-(3-bromo-phenyl)-2-oxo-ethylsulfanyl]-4-(4-hydroxy-phenyl)-pyridine-3,5-dicarbonitrile 
• 731822-77-8 2-(3-bromophenyl)-8-methylimidazo[1,2-a]pyridine-6-carbonitrile 
• 886462-67-5 (3-bromophenyl)[5-(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)-4-(pyridin-4-yl)thiophen-2-yl]methanone 

Relevant articles and documents

Thiazole ring-containing amide compounds as well as preparation method and application thereof

The invention discloses thiazole ring-containing amide compounds as well as a preparation method and application thereof, and belongs to the field of chemical technologies and pesticides. According to the present invention, p-phenylenediamine is adopted as a raw material to synthesize a series of the thiazole ring-containing amide compounds, and the synthesized thiazole ring-containing amide compounds have good inhibition effects on Xanthomonas oryzae pv.Oryza (Xoo), Xanthomonas oryzae pv.Oryzcola (Xoc) and Xanthomonas axonophora pv.Citri (Xac) in agricultural diseases and insect pests, and can be used for preparing the anti-plant bacterium agent.

Novel BuChE-IDO1 inhibitors from sertaconazole: Virtual screening, chemical optimization and molecular modeling studies

In our effort towards the identification of novel BuChE-IDO1 dual-targeted inhibitor for the treatment of Alzheimer's disease (AD), sertaconazole was identified through a combination of structure-based virtual screening followed by MM-GBSA rescoring. Preliminary chemical optimization was performed to develop more potent and selective sertaconazole analogues. In consideration of the selectivity and the inhibitory activity against target proteins, compounds 5c and 5d were selected for the next study. Further modification of compound 5c led to the generation of compound 10g with notably improved selectivity towards BuChE versus AChE. The present study provided us with a good starting point to further design potent and selective BuChE-IDO1 inhibitors, which may benefit the treatment of late stage AD.

An umpolung oxa-[2,3] sigmatropic rearrangement employing arynes for the synthesis of functionalized enol ethers

An oxa-[2,3] sigmatropic rearrangement involving arynes is reported featuring the umpolung of ketones, where the C=O bond polarity is reversed. The in situ-generated sulfur ylides from β-keto thioethers and arynes undergo efficient rearrangement allowing the facile and robust synthesis of functionalized enol ethers in high yields and excellent functional group compatibility. Preliminary mechanistic studies rule out the possibility of Pummerer-type rearrangement operating in this case.